ArticleWhat Makes a Kinase Promiscuous for Inhibitors?
-
Add time:08/30/2019 Source:sciencedirect.com
SummaryATP-competitive kinase inhibitors often bind several kinases due to the high conservation of the ATP binding pocket. Through clustering analysis of a large kinome profiling dataset, we found a cluster of eight promiscuous kinases that on average bind more than five times more kinase inhibitors than the other 398 kinases in the dataset. To understand the structural basis of promiscuous inhibitor binding, we determined the co-crystal structure of the receptor tyrosine kinase DDR1 with the type I inhibitors dasatinib and VX-680. Surprisingly, we find that DDR1 binds these type I inhibitors in an inactive conformation typically reserved for type II inhibitors. Our computational and biochemical studies show that DDR1 is unusually stable in this inactive conformation, giving a mechanistic explanation for inhibitor promiscuity. This phenotypic clustering analysis provides a strategy to obtain functional insights not available by sequence comparison alone.
We also recommend Trading Suppliers and Manufacturers of protein kinase inhibitor peptide (cas 128022-93-5). Pls Click Website Link as below: cas 128022-93-5 suppliers
Prev:Research paperEffects of rigidity on the selectivity of protein kinase inhibitors
Next:Reviewprotein kinase inhibitor peptide (cas 128022-93-5) (PKI): A family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Reviewprotein kinase inhibitor peptide (cas 128022-93-5) (PKI): A family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function08/31/2019
- Research paperEffects of rigidity on the selectivity of protein kinase inhibitors08/29/2019
- Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation08/28/2019
- Targeting kinase signaling pathways with constrained peptide scaffolds☆08/27/2019
- Invited ReviewCyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs08/26/2019
- Review articleSmall molecule modulators targeting protein kinase CK1 and CK208/25/2019
- Detection of casein kinase II by aggregation-induced emission08/24/2019
- Ultrasensitive peptide-based electrochemical detection of protein kinase activity amplified by RAFT polymerization08/23/2019
- Research paperPyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitors08/22/2019
-
Health and Chemical more >


